RxDoctor Payments Data

Renee Marchegiani, DO

Pain Medicine · Wasilla, AKNPI 1982192282

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 49.8% of the total. Reporting peaked in 2022 at $3,756 and has fallen 85.1% since, to $561 in 2025. Among pain medicine clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,323in general payments, 2019–2025

Across 170 payments — averaging $60.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Medtronic$2K
  • Stryker$1K
  • Nevro Corp.$401
  • Abbott$344
  • AbbVie$172
  • plus $671 from 13 others

What the payments were for

  • Travel & lodging$5,15150%
  • Food & beverage$5,14250%
  • Education$300%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,323 in reported general payments places this provider in the 90th percentile of 20 pain medicine providers in Alaska.

See all pain medicine providers in Alaska

Medicare billing

Part B allowed, 2024
$726,692
Medicare patients
882
Services billed
21,961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin54$887
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$428
Oxycodone Hcl19$371
Celecoxib24$250
Pregabalin16$240
Nortriptyline Hcl13$153
Doxycycline Hyclate20$152
Baclofen19$142
Tizanidine Hcl26$109
Cyclobenzaprine Hcl15$107
Alprazolam26$15

Paid to pharmacies, not to this prescriber.

Other pain medicine in Wasilla

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →